基本信息
浏览量:235
职业迁徙
个人简介
We study T cell biology in health and disease. Our current study is divided into two parts. Part I is to investigate T lymphocyte-mediated anti-caner immunity. We have found that host complement inhibits the cytokine IL-10 production in CD8+ tumor infiltrating lymphocytes through complement receptors C3aR and C5aR. Complement-deficient animals are resistant to tumor development in a T cell- and IL-10-dependent manner. CD8+ tumor infiltrating T cells express IL-10 when complement signaling is disabled. We found that tumor infiltrating lymphocytes from human cancers expanded with IL-2 plus IL-10 are potent tumor killers. Complement-mediated inhibition on antitumor immunity is independent of the PD-1/PD-L1 immune checkpoint pathway. Our findings suggest that complement receptors C3aR and C5aR expressed on CD8+ tumor infiltrating lymphocytes represent a novel class of immune checkpoints that needs to be targeted for tumor immunotherapy. Our current effort is to enhance cancer immunotherapy through several strategies. First, we investigate a combined blockade of complement signaling and anti-PD-1 to enhance the antitumor efficacy; second, we are studying the antitumor efficacy of a targeted delivery of IL-10 to antitumor CD8+ T cells by using anti-PD1-IL-10 or anti-CTLA-4-IL-10 fusion proteins; third, we are studying the tumor killing efficacy of addition of IL-10 in the expansion protocol of tumor infiltrating lymphocytes for adaptive cellular therapy.
研究兴趣
论文共 181 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2024): 1302490-1302490
Journal of immunology (Baltimore, Md. : 1950) (2024)
Research Square (Research Square) (2023)
引用0浏览0引用
0
0
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESno. 24 (2023): 17319
Journal of Pharmaceutical Analysisno. 6 (2023): 616-624
Breast Cancer Research and Treatmentno. 1 (2023): 1-17
The Journal of investigative dermatologyno. 5 (2023): 699-710.e10
Yu Wang,Sheng-Nan Sun,Qing Liu, Yang-Yang Yu, Jian Guo,Kun Wang,Bao-Cai Xing, Qing-Feng Zheng,Michael J. Campa,Edward F. Patz,Shi-You Li,You-Wen He
crossref(2023)
Molecular cancer therapeuticsno. 6 (2023): 778-789
Current Research in Immunology (2022): 118-127
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn